tirzepatide 5mg 0.5 ml Mounjaro 5 mg / Vial - Mounjaro (Tirzepatide) Injection 7.5 mg/0.5 mL Prefilled Syringes are a type of medication used to treat type 2 diabetes Tirzepatide solution for Injection 5mg/0.5

Each batch carries a Janoshik Analytical Certificate of Analysis covering HPLC purity quantification and MS identity confirmation

10.1038/s41591-022-01707-4 [EL 1

Lancet Diabetes and Endocrinology, 8, 477489.

Key topics to discuss include: Your Crohn's disease history : Inform your doctor about the severity and pattern of your Crohn's disease, including recent flares, current symptoms, and any complications such as strictures or fistulae

*Based on the average weight loss as reported by patients without diabetes who reached and maintained a dose of 2.4 mg/week of GLP-1 treatment, along with a reduced-calorie diet and increased physical activity